Clinical Trial Update: Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis [Phase 3]

View source ↗

Summary

A Phase III trial evaluating Monolaurin Cream Therapy for congenital ichthyosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ichthyosis

Drugs mentioned

• Monolaurin Cream Therapy

Snippet

Sponsor: Cellegy Pharmaceuticals | Conditions: Ichthyosis | Phase 3 | Status: COMPLETED